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Background: Dihydroxylation of tandemly linked aromatic carbons in a cis-configuration, catalyzed by
multicomponent oxygenase systems known as Rieske nonheme iron oxygenase systems (ROs), often constitute the
initial step of aerobic degradation pathways for various aromatic compounds. Because such RO reactions inherently
govern whether downstream degradation processes occur, novel oxygenation mechanisms involving oxygenase
components of ROs (RO-Os) is of great interest. Despite substantial progress in structural and physicochemical
analyses, no consensus exists on the chemical steps in the catalytic cycles of ROs. Thus, determining whether
conformational changes at the active site of RO-O occur by substrate and/or oxygen binding is important.
Carbazole 1,9a-dioxygenase (CARDO), a RO member consists of catalytic terminal oxygenase (CARDO-O), ferredoxin
(CARDO-F), and ferredoxin reductase. We have succeeded in determining the crystal structures of oxidized CARDO-
O, oxidized CARDO-F, and both oxidized and reduced forms of the CARDO-O: CARDO-F binary complex.
Results: In the present study, we determined the crystal structures of the reduced carbazole (CAR)-bound,
dioxygen-bound, and both CAR- and dioxygen-bound CARDO-O: CARDO-F binary complex structures at 1.95, 1.85,
and 2.00 Å resolution. These structures revealed the conformational changes that occur in the catalytic cycle.
Structural comparison between complex structures in each step of the catalytic mechanism provides several
implications, such as the order of substrate and dioxygen bindings, the iron-dioxygen species likely being
Fe(III)-(hydro)peroxo, and the creation of room for dioxygen binding and the promotion of dioxygen binding in
desirable fashion by preceding substrate binding.
Conclusions: The RO catalytic mechanism is proposed as follows: When the Rieske cluster is reduced, substrate
binding induces several conformational changes (e.g., movements of the nonheme iron and the ligand residue)
that create room for oxygen binding. Dioxygen bound in a side-on fashion onto nonheme iron is activated by
reduction to the peroxo state [Fe(III)-(hydro)peroxo]. This state may react directly with the bound substrate, or O–O
bond cleavage may occur to generate Fe(V)-oxo-hydroxo species prior to the reaction. After producing a cis-
dihydrodiol, the product is released by reducing the nonheme iron. This proposed scheme describes the catalytic
cycle of ROs and provides important information for a better understanding of the mechanism.* Correspondence: anojiri@mail.ecc.u-tokyo.ac.jp
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Many studies have demonstrated that aromatic ring dihy-
droxylation plays a primary role in the initial step of aer-
obic bacterial degradation pathways for various natural
and synthetic aromatic compounds, including dioxins,
polychlorinated biphenyls, and crude oil components such
as polycyclic aromatic hydrocarbons and heterocyclic aro-
matic compounds [1-7]. Such ring dihydroxylation is cata-
lyzed by multicomponent oxygenase systems known as
Rieske nonheme iron oxygenase systems (ROs). A
member of ROs, called as aromatic ring-hydroxylating
dioxygenase, catalyze the incorporation of both oxygen
atoms of molecular dioxygen as two hydroxyl groups
to tandemly linked carbon atoms of an aromatic ring
in a cis-configuration. The introduction of both oxygen
atoms into aromatic substrates is a key reaction to ini-
tiate the transformation of relatively unreactive aromatic
compounds, and novel oxygen activation and the
addition mechanism of ROs is a subject of great interest.
Despite substantial progress in understanding the struc-
ture, regulation, and kinetics of ROs in recent studies
[8], no consensus exists on the chemical steps in the
catalytic cycle. Further knowledge of the mechanism can
lead us to improved application of this important class of
enzymes for not only the bioremediation of various en-
vironmentally relevant aromatic compounds, but also the
synthesis of the chiral precursor compounds [9].
The multicomponent systems of ROs typically com-
prise the terminal oxygenase component and the elec-
tron transport chain, which consists of either one or two
separate proteins: reductase alone or ferredoxin and re-
ductase in combination [1]. Biochemical and/or struc-
tural properties of several terminal oxygenase
components of RO (RO-Os) have demonstrated that
RO-Os have a mononuclear iron site and a Rieske-type
[2Fe-2 S] cluster (Rieske cluster) in common [10]. The
mononuclear iron site activates dioxygen for reaction
with the substrate, and the Rieske cluster transfers elec-
trons to the mononuclear iron site during the catalytic
cycle. The structures of RO-Os reveal that each α-
subunit contains a mononuclear iron site and a Rieske
cluster separated by a distance of approximately 45 Å.
However, the functional pair appears to be constituted
by the mononuclear iron and the Rieske cluster in
neighboring subunits located within ~12 Å distance. The
nonheme iron site is coordinated by two histidine resi-
dues and one carboxylate residue called the 2-His-1
-carboxylate facial triad, which is a versatile platform of
nonheme iron-containing oxygenases including ROs
[11]. In most RO-O structures, the carboxylate residue
is coordinated to the iron in a bidentate manner [12-17],
although monodentate structures have also been
reported [18-22]. Additional water molecules are found
to be coordinated to the nonheme iron, forming a five-or six-coordinate catalytic ferrous site, depending
on the number of water molecules. The Rieske cluster
has two iron and two sulfides; one iron is coordinated
by two histidine residues, and the other is coordinated
by two cysteine residues. The nonheme iron site and
the Rieske cluster can be bridged by a conserved as-
partate residue located at the subunit interface, which
may be important for electron transfer [23] and regu-
lation [24] during the catalytic cycle.
The metal site composition of RO-Os generally sug-
gests that three oxidation states can stably exist: both
metal sites are oxidized, the Rieske cluster is oxidized
and mononuclear iron is reduced, and two metal sites
are reduced. Another potential oxidation state with a
reduced Rieske cluster and oxidized mononuclear iron is
not stable because of the relative redox potentials of the
metal sites. Spectroscopic studies report that substrate
binding and dioxygen activation occur at the mono-
nuclear iron center for naphthalene 1,2-dioxygenase
(NDO) and benzoate 1,2-dixoygenase (BZDO) [25-28].
Wolf et al. demonstrated that the oxygenase component
of BZDO (BZDO-O) alone in the fully reduced state
could activate dioxygen and generate the cis-dihydrodiol
product in a single turnover reaction [26]. Following the
single turnover of BZDO-O, this protein was found to
be in the fully oxidized state with most of the products
retained in the active site, suggesting that the mono-
nuclear iron and Rieske cluster each provide one of two
electrons required by the reaction stoichiometry. The
same was found to be true for the oxygenase component
of NDO (NDO-O), which produced an essentially stoi-
chiometric yield of product in a single turnover based
on the number of populated mononuclear irons present
[25]. The binding of the dioxygen to the ferrous catalytic
site was regulated by both substrate binding and Rieske
cluster reduction, implying that a structural change
occurs in the vicinity of the ferrous iron site during the
catalytic cycle. Indeed, this was demonstrated from crys-
tallography for an allosteric effect of the Rieske cluster
in 2-oxoquinoline 8-monooxygenase (OMO) [14]. Mar-
tins et al. showed that reduction of the Rieske cluster
modulated the ferrous nonheme iron through a chain of
structural changes across the subunit interface, resulting
in the movement of the nonheme iron and its ligand his-
tidine away from a substrate-binding site [14]. The fer-
rous nonheme iron changes from five- to six-coordinate,
which was also found for NDO [25], BZDO [26], and
phthalate 4,5-dioxygenase (PDO) [24,29]. However, the
crystal structures of the ferrous nonheme iron in NDO
[13] and carbazole (CAR) 1,9a-dioxygenase (CARDO)
[16] with a reduced Rieske cluster are five-coordinate,
which differs from OMO-O. In addition, binding of the
substrate to the active site of RO-Os is a key step in
regulating the reactivity toward dioxygen. Until now,
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component of PDO (PDO-O) found that the NDO-O
(Rieske cluster is either oxidized or reduced) and PDO-
O with the oxidized Rieske cluster showed conversion of
ferrous iron from six- to five-coordinate upon binding of
the substrate to the active site [30-32]. However, the
crystal structures of the nonheme iron site in the native
and substrate-bound forms of NDO-O did not indicate a
significant change in the coordination environment,
maintaining five-coordinate structures [13]. The five-
coordinate nonheme iron in the oxygenase component
of OMO (OMO-O) with the oxidized Rieske cluster also
did not show a change in coordination number even
when a substrate was bound to the active site [14]. On
the other hand, Daughtry et al. have reported that five-
coordinate geometry leaves one site open for oxygen
binding and activation or the single solvent ligand could
be displaced by oxygen binding, compared between the
unliganded and the substrate binding structures of sta-
chydrine demethylase [33]. As noted above, spectroscopy
and current crystal structures have provided different
perspectives of the catalytic mechanism involved in ROs.
The observation that two electrons present in the
Rieske cluster and the mononuclear iron of NDO-O and
BZDO-O are used during a single turnover supports the
mechanism by which dioxygen is activated by reduction
to the peroxo state after binding to the active site iron
[Fe(III)-(hydro)peroxo]. Following dioxygen activation,
this state is considered to react directly with bound sub-
strate or to result in O–O bond cleavage generating Fe
(V)-oxo-hydroxo species prior to reaction [8,34,35]. An
alternative mechanism involves an additional step in
which one electron is donated to the initially formed Fe
(III)-(hydro)peroxo to produce the Fe(II)-(hydro)peroxo
intermediate, which could react either directly or as Fe
(IV)-oxo-hydroxo species after O–O bond cleavage. The
latter mechanism is supported by studies that used
PDO-O in which the mononuclear iron was left in Fe(II)
state after yielding product [29,36], while single turnover
occurred as observed for NDO-O and BZDO-O. These
studies suggest that an additional electron was trans-
ferred to the nonheme iron at some stage of the catalytic
cycle from a Rieske cluster in a neighboring α-subunit.
To understand the molecular basis of the catalytic
cycle, Karlsson et al. formed complex crystals of NDO-O
with substrate, dioxygen, substrate plus dioxygen, or
product and determined their structures by X-ray crys-
tallography [13]. The complex structure with substrate
and dioxygen showed that dioxygen was bound to the
nonheme iron in a side-on fashion, which allowed each
oxygen atom to attack the neighboring aromatic carbon
atom from the same face of a planar aromatic ring, pro-
ducing a cis-dihydrodiol. In addition, based on the Fe–O
bond lengths in the crystal structure, the complex islikely to be an Fe(III)-(hydro)peroxo species. However,
conformational changes by the binding of substrate and/
or oxygen in the above-mentioned crystal structures
were hardly observed. In these situations, determining
whether conformational changes including coordination
conversion at the active site occur by binding of sub-
strate and/or oxygen is very important for a better
understanding of the catalytic mechanisms in ROs.
We have investigated the enzymatic function of CAR-
DOs, members of ROs, from various bacteria: Pseudo-
monas resinovorans CA10, Janthinobacterium sp. J3,
Novosphingobium sp. KA1, and Nocardioides aromatici-
vorans IC177 [7,37]. All CARDOs commonly consist of
three components: terminal oxygenase (CARDO-O), fer-
redoxin (CARDO-F), and ferredoxin reductase
(CARDO-R). We determined the structures of CARDO-
Os of J3 and IC177 [15,17] and CARDO-Fs of CA10 and
IC177 [17,38]. In addition, the structures of the
CARDO-O: CARDO-F binary complex were determined
in non-reduced, reduced, and CAR-bound forms using
CARDO-O of J3 and CARDO-F of CA10 [16]. These
structures provide a structure-based interpretation of
inter-component electron transfer between two Rieske
clusters of ferredoxin and oxygenase in ROs as well as,
conformational changes upon CAR binding, which result
in the closure of a lid over the substrate-binding pocket
[16].
In the present study, we used CARDO-O of J3 and
CARDO-F of CA10, hereafter simply termed Oxy and
Fd, respectively, and aimed to clarify the holistic catalytic
mechanism including conformational changes in ROs by
determining various structures of the Oxy:Fd binary
complex at different steps.
Results and discussion
Overview
Although Oxy:Fd binary complexes in non-reduced,
reduced, and non-reduced CAR-bound forms were
called Binary Complex, Complexred, and Complexsubs,
respectively, in a previous paper (PDB code 2DE5, 2DE6,
and 2DE7) [16], they were respectively renamed Oxy:
Fdrest [(1) in Figure 1], Oxy: Fdred (2), and Oxy: FdCAR
(2’) in this paper, because the non-reduced complex can
be considered to be in the resting state in the catalytic
cycle and because the CAR-bound complex was
obtained using resting state crystals soaked in a CAR-
containing crystallization solution under aerobic condi-
tions. UV-visible absorption spectra of the crystals of
Oxy: Fdrest and Oxy: Fdred were previously measured by
single-crystal microspectrophotometer [39], suggesting
that Rieske clusters in Oxy: Fdrest and Oxy: Fdred were
oxidized and reduced, respectively (Figure 2) [16]. We
did not measure the absorption spectra of crystals


















































Figure 1 Proposed catalytic cycle of CARDO on the basis of various Oxy:Fd complex structures. Statuses are as follows: (1) the resting
state with the oxidized Rieske cluster and the ferrous nonheme iron (Oxy: Fdrest, PDB code 2DE5) [16]; (2) the reduced state (Oxy: Fdred, PDB code
2DE6) [16]; (2’) the CAR-bound state (Oxy: FdCAR, PDB code 2DE7) [16]; (3) the reduced CAR-bound state (Oxy: Fdred-CAR, PDB code 3VMG); (3’) the
oxygen-bound state (Oxy: FdO2, PDB code 3VMH); (4) the CAR- and oxygen-bound state (Oxy: FdCAR-O2, PDB code 3VMI); and (5) the product-
bound state. [2Fe-2 S] shows the coupling Rieske [2Fe-2 S] cluster of the neighboring Oxy subunit, and nonheme iron ligands in the active site
are omitted. Solid arrows indicate the proposed main pathway in the catalytic cycle, and broken arrows show the possible pathway based on the
complex structures determined in previous and present studies. Red and blue letters show the oxidized and reduced states of redox centers,
respectively. The subscripts “ox” and “red” also indicate the oxidized and reduced states, respectively, of the Rieske [2Fe-2 S] cluster.
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to be oxidized, because of the fact that Oxy: FdCAR was
obtained by soaking with CAR-containing solution of
resting state crystals at atmospheric condition. On the
other hand, this spectroscopic analysis did not provide
information on the redox state of the nonheme iron.
In the present study, we determined the crystal struc-
tures of the reduced CAR-bound Oxy:Fd complex (Oxy:
Fdred-CAR), oxygen-bound Oxy:Fd complex (Oxy: FdO2),
and both CAR- and oxygen-bound Oxy:Fd complex
(Oxy: FdCAR-O2) at 1.95, 1.85, and 2.0 Å resolution, re-
spectively. To ensure redox state of the Rieske cluster of
the crystals, absorption spectra of oxygen-bound Oxy:Fd
crystal was measured as described previously [16]. An
absorption pattern similar to that of Oxy: Fdrest crystal
was observed, suggesting that Rieske clusters in oxygen-
bound Oxy:Fd (Oxy: FdO2) crystals were re-oxidized by
dioxygen binding/exposure (Figure 2). Although we did
not determined the absorption spectra of CAR-soaked
Oxy:Fd crystals, the Rieske clusters of Oxy: Fdred-CAR
and Oxy: FdCAR-O2 crystals were presumed to be
reduced and oxidized, respectively, because the methodsfor dithionite treatment and O2 exposure were similar to
those in preparation of Oxy: Fdred and Oxy: FdO2, re-
spectively. Statuses around ferrous iron in the active site
and the Rieske cluster of the Oxy: Fdred-CAR, Oxy: FdO2,
and Oxy: FdCAR-O2 are (3), (3’), and (4), respectively, in
Figure 1. Crystal data and refinement statistics of the
three determined Oxy:Fd structures in this paper are
summarized in Table 1. All Oxy:Fd structures solved
consist of one molecule of Oxy (comprising three subu-
nits: chains A, B, and C) and three molecules of Fd
(chains D, E, and F), and the asymmetric unit of the
crystal contains one Oxy:Fd structure. Three molecules
of Fd bind to the subunit boundary of one Oxy mol-
ecule. The superposition of three Fd molecules binding
to one Oxy molecule in each Oxy:Fd structures resulted
in a root mean square deviation (RMSD) of 0.47-0.51 Å
(104 Cα atoms) and no evident conformational differ-
ences. In addition, comparisons of Fd structures among
the three structures also revealed no clear conform-
ational changes (RMSD, 0.16-0.19 Å in 104-107 Cα
atoms) with the exception of a clear movement of the

































Figure 2 UV-visible absorption spectra of the Rieske cluster in crystals and the mixed solution. The absorption spectra of crystals of the
resting state [Oxy: Fdrest, (1) in Figure 1], reduced state [Oxy: Fdred, (2)], and oxygen-bound state [Oxy: FdO2, (3’)] under a cryo-stream of nitrogen
at 100 K are shown in curves 1, 2, and 3, respectively, in the main panel. In the inset, curve 1 in the small panel shows the non-reduced spectrum
of the mixed solution of purified CARDO-O and CARDO-F, which were used for crystallization. Curve 2 in the inset represents the spectrum after
the addition of sodium dithionite to the same mixed solution. (Curves 1 and 2 from both crystal and solution are referred from our previous
study) [16].
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ously [16]. In contrast, some recognizable conform-
ational changes were observed resulting from reduction/
substrate-binding around the active site iron and in the
substrate-binding pocket of Oxy subunits of these Oxy:
Fd structures. Structural differences among the three
subunits of one Oxy molecule mainly occurred by CAR
binding. The electron density maps of CAR were only
found in chains B and C, because the symmetry-related
structure partially filled the entrance of the substrate-
binding pocket in chain A (Table 2).
The reduced oxy:Fd complex structure bound with CAR
[oxy: Fdred-CAR, (3)]
Using Oxy: Fdrest crystals soaked in a crystallization so-
lution containing sodium dithionite and CAR, we
obtained the structure of reduced Oxy:Fd complex
bound with CAR, Oxy: Fdred-CAR [(3) in Figure 1]. Oxy:
Fdred-CAR provided the same observations as those of
Oxy: FdCAR (2’), which were a clear density for a flat aro-
matic compound in the active site (Additional file 1:
Figure S1A and Table 2) and the CAR-binding-
dependent movement of amino acid residues Leu202–
Thr214 and Asp229–Val238 toward the entrance of the
substrate-binding pocket in chains B and C (data not
shown) [16]. A comparison of the structures between
Oxy: Fdred-CAR (3) and Oxy: Fdrest (1)/Oxy: FdCAR (2’)
revealed a shift of approximately 0.7 Å in the phenyl
group of Fd Phe67 opposite the Rieske cluster. Theslight movement of Phe67 in Oxy: Fdred-CAR was com-
mon in Oxy: Fdred, in which the single-crystal micro-
spectrophotometer clearly confirmed the reduced status
of the Rieske cluster [16]. This suggests that this slight
movement of Phe67 may be specific for reduction of the
Rieske cluster. The active site of Oxy: Fdred-CAR showed
a six-coordinate, distorted octahedral geometry with two
water ligands, while that of Oxy: FdCAR (2’) could be
described as a distorted tetragonal geometry with one
water ligand (Figure 3A). Although one water ligand was
located at almost the same position as the water ligands
of the Oxy: FdCAR structure, the location of the other
had moved toward Asp333, the ligand of the nonheme
iron, and the observed average bond length between
two water molecules was 2.7 Å. The position of the
two water ligands was similar to that in the reduced
OMO-O structure obtained by crystallization under
anoxic conditions (Figure 3B).
Orientations of CAR were virtually identical between
Oxy: Fdred-CAR and Oxy: FdCAR as shown in Figure 3A,
clearer density and lower temperature factors were
observed under the reduced condition (substrate’s aver-
age temperature factors: 28.8 Å2 in reduced crystal and
35.1 Å2 in non-reduced crystal), suggesting that CAR is
bound to the active site more stably when the Rieske
cluster is reduced. Notably, the nonheme iron and its
ligand residue, Asp333, moved away from CAR by
approximately 0.5 and 0.4 Å, respectively, in Oxy:
Fdred-CAR (Figure 3A). In addition, compared with







(Oxy: Fdred-CAR) (Oxy: FdO2) (Oxy: FdCAR-O2)
Crystal Data
Space group P21 P21 P21
Unit cell parameters (Å, °) a= 98.2, b= 89.8, a= 98.2, b= 89.4, a= 98.0, b= 89.6,
c= 105.2, c= 105.0, c= 104.8,
β = 104.4 β = 104.1 β = 104.2
Completeness (%)a 99.9 (99.9) 99.9 (99.4) 99.3 (97.6)
Rmerge
b (%)a 8.1 (33.8) 6.0 (36.3) 6.3 (31.2)
Resolution range (Å)a 50.0-1.95 (2.02-1.95) 50.0-1.85 (1.92-1.85) 50.0-2.00 (2.07-2.00)
Total no. of reflections 684,339 841,651 422,706
No. of unique reflections 128,789 (12,781) 150,169 (14,838) 117,108 (11,459)
Refinement
Resolution range (Å)a 40.6-1.95 (2.02-1.95) 47.6-1.85 (1.92-1.85) 32.7-2.00 (2.07-2.00)
R-factor (%)c 19.8 19.6 20.5
Rfree (%)
d 21.9 22.5 24.0
Root mean square deviation (RMSD)
Bond length (Å) 0.005 0.005 0.006
Bond angles (°) 1.3 1.3 1.3
Model composition and average B factor (Å2)
All 2521, 29.2 2716, 32.0 2337, 40.6
Residues 1482, 28.6 1483, 31.1 1481, 40.2
Water 1037, 36.3 1230, 40.4 851, 45.6
CAR 2, 28.8 –, – 2, 48.2
Dioxygen –, – 3, 36.4 3, 50.9
Ramachandran plote
Favored region (%) 96.4 95.9 95.4
Allowed region (%) 3.4 3.9 4.4
Outlier region (%) 0.2 0.2 0.3
a Values in parentheses are for the outermost shell.
b Rmerge = Σh Σl |Ihl -< Ih> |/Σh Σl< Ih>, where Il is the lth observation of reflection h and< Ih> is the weighted average intensity for all observations l of
reflection h.
c R-factor is defined as R = Σ||Fobs| - |Fcalc||/Σ|Fobs|.
d Rfree was calculated using 5% of the unique reflections.
e Ramachandran plot was analyzed with RAMPAGE [40].
Ashikawa et al. BMC Structural Biology 2012, 12:15 Page 6 of 14
http://www.biomedcentral.com/1472-6807/12/15Oxy: Fdred (2), the movements of the nonheme iron and
Asp333 upon CAR binding were approximately 0.9 and
0.7 Å, respectively (Figure 3C). Small conformational
changes were also observed in residues around Asp333
(residues 332–339) on the distorted helix α11, forming
the active site, with shifts between 0.3 and 0.8 Å for the
Cα atoms (Figure 4). The histidine ligands adapted to
the movement of the iron with rather small changes in
their side chain conformation. In addition, the side chain
of Asn177 shifted toward Asp333, although the helix α6,
including Asn177, had slight movement (Figure 4). In
chains B and C of Oxy: Fdred-CAR, the average bondlengths between mononuclear iron–Asp333OD1 and
mononuclear iron–Asp333OD2 changed from 2.0 Å to
1.9 Å and from 2.6 Å to 2.2 Å, respectively, which made
the coordination of the carboxylate residue to nonheme
iron clearly bidentate (Table 3). Similar conformational
changes were reported in nitrobenzene 2,3-dioxygenase
(NBDO) bound with substrates [20]. In many iron
enzymes that utilize dioxygen, the long helices contain-
ing some ligands were to some extent distorted [41,42].
Because such distortion has been considered to provide
a dioxygen accommodation pathway or increase con-
formational flexibility, it was also suggested for CARDO
Table 2 Substrate-binding statuses in each subunit of
Oxy in the catalytic cycle
Statea Oxy subunits






























a Numbers correspond to Figure 1.
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creating an accommodation route for the dioxygen mol-
ecule. In the reduced structure of OMO-O without the
substrate, it was also reported that reduction of the
Rieske cluster displaced the nonheme iron 0.8 Å away
from the substrate-binding site [14]. However, an elec-
tron nuclear double resonance (ENDOR) study on
naphthalene-bound NDO-O with a reduced Rieske clus-
ter showed that the substrate was displaced 0.5 Å away
from the nonheme iron compared with that in an oxi-
dized Rieske cluster [27,28]. In the case of CARDO-O,
reduction upon substrate binding triggered displacement
of the nonheme iron and residues including Asp333
away from the substrate, which increased the accessible
surface at the mononuclear iron, opened room for
dioxygen binding, and allowed binding of an exogenous
sixth water ligand. In other words, movement of the
nonheme iron away from the substrate when the Rieske
cluster is reduced might act as a physical mechanism of
gating oxygen reactivity. Furthermore, the conform-
ational changes observed upon CAR-binding and reduc-
tion experimentally demonstrate the hypothesis in the
previous spectroscopic studies by Wolfe et al.: dioxygen
binding at the mononuclear iron site is controlled by
substrate binding to the enzyme when the Rieske cluster
is reduced [25,26].The oxygen-bound complex structure [oxy: FdO2, (3’)]
To obtain the oxygen-bound complex structure, Oxy:
Fdred crystals were transferred to a crystallization solu-
tion for oxygen exposure. As a result, clear electron
density corresponding to two atoms, such as oxygen
atoms, was observed in all three chains (Additional file
1: Figure S1B and Table 2). As shown in Figure 2, Rieskecluster of the Oxy: FdO2 crystal was proven to be oxi-
dized. The positions of these exogenous atoms were
roughly similar to those of dioxygen bound to NDO-O
[13]. Although the chemical nature of these exogenous
atoms was not clear, we tentatively added a dioxygen
molecule to the electron density in the model by refer-
ring to NDO-O [13]. To determine the type of dioxygen
species present in the crystals, we refined the dioxygen
species with an unrestrained O–O distance. As a result,
the O–O distance was refined to be approximately 1.5-
1.6 Å. Such a distance between oxygen atoms suggests
that the dioxygen species was a peroxide species. Thus,
the O–O distance of the putative peroxide molecule was
refined under the restraint of 1.45 Å, and we determined
the oxygen-bound complex structure [Oxy: FdO2, (3’) in
Figure 1].
In the final model, the O–O distance in the putative
peroxide molecule was refined to 1.45 Å, and the aver-
age temperature factors of the oxygen atoms were
refined to 37.2 Å2 (O1) and 35.6 Å2 (O2), which were
similar to those of all residues (29.7 Å2) and the non-
heme iron (31.0 Å2) in chains A to C. The O2 atom
was liganded to the nonheme iron (2.0 Å), whereas
the O1 atom was remote from the nonheme iron
(2.6 Å) (Table 3). In the binary complex structure of
NDO-O with dioxygen, the distances of two oxygen
atoms from the iron were comparable (2.1 and 2.3 Å)
[13]. Thus, the orientation of dioxygen bound to the
nonheme iron between the active sites of CARDO-O
and NDO-O was significantly different, and the dioxy-
gen molecule was found to bind with the Oxy: FdO2
crystal in an end-on fashion (Additional file 1: Figure
S1B and 3D). Previously, the mononuclear iron(III)
species with end-on and side-on peroxides was pro-
posed or identified in the catalytic cycles of the antitu-
mor drug bleomycin and various enzymes [43]. Roelfes
et al. reported the characterization of the model com-
plex of Fe(III)-peroxo species with resonance Raman
spectroscopy and suggested that the Fe(III)-peroxo
complex (side-on binding) and Fe(III)-hydroperoxo
complex (end-on binding) were interchangeable by
treatment with an appropriate acid or base [41]. In the
case of the Oxy: FdO2 structure, because the pH of the
crystallization solution was low (around 5.5), the iron-
peroxo species in Oxy: FdO2 was proposed to be Fe
(III)-hydroperoxo. Studies of NDO and BZDO using
nitric oxide and dioxygen, however, have shown that
reactivity at the active site is regulated by both the
redox state of the Rieske cluster and the presence of
substrate. Especially with dioxygen, no reaction occurs
in the absence of an aromatic substrate if the Rieske
cluster is oxidized [25,26]. Thus, it was expected that
substrate binding regulates the manner of dioxygen















Figure 3 Superimpositions of the active site of chain C in complex structures. (A) Oxy: Fdred-CAR [(3), magenta] and Oxy: FdCAR [(2’), yellow].
Only the nonheme iron (sphere), waters liganded to the iron (small sphere), iron-coordinated residues (H183, H187, and D333; stick), and CAR
(stick) are shown. (B) Oxy: Fdred-CAR [(3), magenta] and OMO-O in the reduced state (PDB code 1Z02, slate) [14]. (C) Oxy: Fdred-CAR [(3), magenta]
and Oxy: Fdred [(2), cyan]. (D) Oxy: FdO2 [(3’), salmon], NDO-O bound with dioxygen only (PDB code 1O7M, orange), and both oxygen and indole
(PDB code 1O7N, lime) [13]. Dioxygen molecule and indole are shown as stick-and-ball and stick, respectively. (E) Oxy: FdCAR-O2 [(4), white], NDO-
O bound with oxygen only (PDB code 1O7M, orange), and both oxygen and indole (PDB code 1O7N, lime) [13]. (F) Oxy: FdCAR-O2 [(4), white] and
Oxy: FdO2 [(3’), salmon]. (G) Oxy: FdCAR-O2 [(4), white], Oxy: FdCAR [(2’), yellow], and Oxy: Fdred-CAR [(3), magenta]. (H) Oxy: FdCAR-O2 [(4), white], Oxy:
FdCAR [(2’), yellow], and Oxy: FdO2 [(3’), salmon].
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Furthermore, despite dioxygen bound to the active site,
the distances between nonheme iron and oxygen
atoms of the carboxyl group of Asp333 in Oxy: FdO2were almost identical to those of Oxy: Fdred (2.0 Å
and 2.7 Å vs. 2.0 Å and 2.6 Å, respectively; Table 3),
and no changes were observed in the positions of the




Figure 4 Conformational changes around the nonheme iron
observed between reduced two Oxy:Fd structures. Superposition
of Oxy: Fdred-CAR [(3) in Figure 1, magenta] and Oxy: Fdred [(2), cyan]
when CAR is bound to the active site with the reduced Rieske
cluster is shown as in Figure 3.
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[oxy: FdCAR-O2, (4)]
The structure obtained from air-treated Oxy: Fdred-CAR
crystals during CAR-soaking seemed to bind with both
CAR and dioxygen. As shown in Additional file 1: Figure
S1C, the Fo-Fc map obtained during the course of crys-
tallographic refinement of this structure showed a large
residual density beside the nonheme iron, suggesting the
existence of a dioxygen species. We refined the dioxygen
species as described in the subsection “The Oxygen-
Bound Complex Structure”, and the O–O distance wasTable 3 Average bond lengths (Å) between nonheme iron an
Statea H183 H187 D333
NE2 NE2 OD1
(1) Resting 2.1 2.2 2.1
(Oxy: Fdrest)
(2) Reduced 2.1 2.1 2.0
(Oxy: Fdred)
(2’) CAR-bound 2.1 2.3 2.0
(Oxy: FdCAR)
(3) Reduced CAR-bound 2.2 2.1 Ab:1.9
(Oxy: Fdred-CAR) B&Cb:2.0
(3’) Oxygen-bound 2.1 2.1 2.0
(Oxy: FdO2)
(4) CAR- and oxygen-bound 2.1 2.1 1.9
(Oxy: FdCAR-O2)
a Numbers correspond to Figure 1.
b Alphabet indicates the chain name.refined to approximately 1.5 Å. Therefore, the dioxygen
species was likely a peroxide species.
In the final model, the distance between two atoms in
the putative peroxide molecule was refined to 1.44 Å
[Oxy: FdCAR-O2; (4) in Figure 1]. Considering the fact
that Rieske clusters of Oxy: FdO2 were experimentally
proven to be oxidized, Rieske clusters of Oxy: FdCAR-O2
crystals were proposed to be oxidized. Based on Fe–O
bond lengths, the complex structure was likely to be Fe
(III)-(hydro)peroxo species that were found in NDO-O
bound with both indole and oxygen and the BZDO-O
peroxide shunt reaction [13,26]. Moreover, the electron
densities corresponding to dioxygen species above the
nonheme iron in the Fo-Fc map differed in all chains of
Oxy: FdCAR-O2. In chains B and C, the locations of
dioxygen species were similar to those of the dioxygen-
bound NDO-O with indole (side-on fashion) [13], which
indicates that the average bond lengths between mono-
nuclear iron–Asp333OD1 and –Asp333OD2 were both
approximately 1.8 Å and bound in a side-on fashion
(Figure 3E and Table 3). The electron density of the
dioxygen molecule at the active site of chain A was iden-
tical to that of Oxy: FdO2 (the bond lengths between
mononuclear iron and oxygen atoms of Asp333 were
2.6 Å and 2.0 Å, respectively, in an end-on fashion)
(Tables 2 and 3). In addition, the electron density of
CAR was not found in the active site of chain A
(Table 2). The average distances between peroxide O1
atom–CAR C9a atom and peroxide O2 atom–CAR C1
atom were both approximately 2.9 Å. This binding man-
ner agrees with the fact that CARDO-O catalyzes the
angular dioxygenation for CAR.
In chains B and C, the average temperature factors of
the oxygen atoms were refined to 53.6 Å2 (O1) andd atoms in the catalytic cycle
D333 CAR CAR Peroxide Peroxide
OD2 C1 C9a O1 O2
2.8 – – – –
2.6 – – – –
2.6 4.3 4.2 – –
Ab:2.7 4.6 4.7 – –
B&Cb:2.2
2.7 – – 2.6 2.0






3.0 Å  
2.7 Å  
3.5 Å  
3.0 Å  
Figure 5 Water molecule proposed as a proton donor for the
peroxide. The water molecule had hydrogen-bonds to Glu284,
Tyr296, and Arg337, which were conserved perfectly in all reported
CARDO-Os.
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than those of all residues (40.3 Å2) and the nonheme
iron (39.9 Å2). The bound CAR also had temperature
factors comparable with those of the dioxygen species
(48.2 Å2) in those chains. These results indicate that
dioxygen species and CAR had high but not full occu-
pancy. Further assessment of Oxy: FdCAR-O2 was carried
out using a simulated annealing omit map for each lig-
and atom. The omit map for each atom of the diatomic
molecule resulted in a residual electron density at the
position of the omitted atom (Additional file 1: Figure
S1C). Considering the fact that CARDO showed scarce
activity at the low pH employed in crystallization (Nam
et al., unpublished results), Oxy: FdCAR-O2 in chains B
and C might be close to the structure of a reactive com-
plex [(5) in Figure 1].
Comparison of the dioxygen species in two dioxygen-
binding structures, (3’) and (4) in Figure 1, indicated that
the orientation of dioxygen bound to the nonheme iron
was roughly similar but that the binding manner was
not (side-on in chains B and C of Oxy: FdCAR-O2 and
end-on in all chains of Oxy: FdO2) (Figure 3F and
Table 3). Based on our data and the proposal by Wolfe
et al. [25,26], we speculated that the above-mentioned
difference in the dioxygen-binding manner was due to
whether the substrate was bound to the active site. That
is, substrate binding might ensure that reactive oxygen
species are prompted to bind to the desirable position
(fashion). In addition, from superimposition, CAR was
found in almost the same position as that found in Oxy:
Fdred-CAR (3) and Oxy: FdCAR (2’) (Figure 3G). The pos-
ition of the dioxygen molecule was similar to that foundin the indole- and oxygen-bound NDO-O [13], suggest-
ing that this position is a common place for binding of
activated dioxygen species in RO-Os (Figure 3E). The
distances between the nonheme iron and oxygen atoms
(OD1 and OD2) of Asp333 in Oxy: FdCAR-O2 were simi-
lar to those in Oxy: FdCAR (2’) and Oxy: FdO2 (3’)
(Table 3), and the nonheme iron moved to a position
close to those in Oxy: FdCAR and Oxy: FdO2 (Figure 3H).
The movement resulted in the fix of reactive oxygen
species at a suitable place for binding in Oxy: FdCAR-O2,
thereby seemingly catching oxygen atoms with substrate
strongly to minimize the risk of leakage and unexpected
reaction. Although further investigation would be
needed to determine what Fe(III)-peroxo species is pro-
tonated, protons are probably delivered through a water
molecule connected to Glu284, Tyr296, and Arg337,
which formed the substrate-binding pocket, because
these three amino acid residues are conserved perfectly
in all reported CARDO-Os (Figure 5).
Conclusions
The series of Oxy:Fd complex structures represented se-
quential steps along with the single turnover reaction, al-
though the structure bound with product has not been
obtained until now. Our findings in the three structures
in this study have provided several important implica-
tions for conformational changes in the catalytic cycle of
ROs. In Oxy: Fdred-CAR, substrate binding under the
reduced condition triggers a shift of both nonheme iron
and its ligand residues, allowing dioxygen to bind to the
active site. The Oxy: FdCAR-O2 structure showed dioxy-
gen bound to the nonheme iron and it was likely to be
an Fe(III)-(hydro)peroxo species. Structural comparison
of Oxy: FdO2 and Oxy: FdCAR-O2 demonstrated the possi-
bility that regulation by the substrate ensures that react-
ive oxygen species bind to the desirable position in an
appropriate side-on fashion.
The scheme of the catalytic mechanism in ROs by in-
tegration of reported findings in various structural and
kinetic studies, including ours, was proposed as follows:
i) The reduced ferrous iron in the active site and the oxi-
dized Rieske cluster is the first state in the catalytic cycle
[(1) in Figure 1]. ii) When the Rieske cluster is reduced
by receiving one electron from redox partner, the sub-
strate binds to the active site. As a result, several con-
formational changes (e.g., movements of the nonheme
iron and the ligand residue) occur, creating space for
oxygen binding [(2) and (3)]. iii) Dioxygen bound in a
side-on fashion to the active site of nonheme iron is
activated by reduction to the peroxo state [Fe(III)-
(hydro)peroxo] [(4)]. This state may react directly with
the bound substrate, or O–O bond cleavage may occur
to generate Fe(V)-oxo-hydroxo species prior to the reac-
tion. iv) After producing a cis-dihydrodiol, the product is
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ond electron from the redox partner as suggested by
Wolfe et al. [25,26], and then the state returns to the
starting state [(5) to (1)].
Some previous reports have suggested that oxygen ac-
tivation at RO-O nonheme iron sites occur through Fe
(IV) and Fe(V) states [25,44,45]. However, Ferraro et al.
proposed that no higher-order oxidation states need to
be invoked for a concerted mechanism leading to cis-
dihydroxylation reactions catalyzed by ROs [10]. This
hypothesis involves the formation of an Fe(III)-(hydro)
peroxo complex, which is supported by several reports
[13,19,33,46,47]. Thus, whether the O–O bond must
break before reaction with aromatic substrates remains
unclear. A recent mechanistic study of NDO using diag-
nostic probe molecules, however, suggested that their
monooxygenation reaction is mediated by an Fe(V)-oxo-
hydroxo intermediate [48]. Alternatively, this high oxida-
tion state would be difficult to achieve in a nonheme
ligand environment [49]. Further study is required to
elucidate the nature and reactivity of the iron-dioxygen
species in ROs. The results presented in this paper pro-
vide an additional basis for further structural investiga-
tions of oxygen binding and activation in biological
systems.
In addition, it is of great interest when and how the
redox partner is associated and then disassociated to the
oxygenase component in the catalytic cycle because few
structure-based interpretations of the interactions
among RO components have been reported. Therefore,
the determination of complex structures between oxyge-
nase and redox partner by X-ray crystallography under
redox-state-controlled conditions will be important.
Methods
Purification and crystallization
CARDO-O from Janthinobacterium sp. J3 and CARDO-
F from Pseudomonas resinovorans CA10 were used as
CARDO components. Both components were purified
as described previously [15,38]. CARDO-F from CA10
has one amino acid mismatch with that from J3, show-
ing 99.1% identity at amino acid sequence level. The
electron transferability between the purified CARDO-O
of J3 and CARDO-F of CA10 was confirmed by detect-
ing oxygenase activity for CAR, and differences of the
catalytic properties between heterologous and natural
combinations were hardly detected for CAR [15,17,50].
The crystallization condition for Oxy:Fd was the same as
that described in our previous study [49].
Preparation of oxy: Fdred-CAR crystals
After Oxy: Fdrest crystals were soaked for 20 min [50] in
a crystallization solution containing 20% (v/v) glycerol,
5% (v/v) dimethylsulfoxide, 0.25% (w/v) CAR, and20 mM sodium dithionite within a well of a microbatch
plate (Hampton Research, Aliso Viejo, CA, USA) and
covered with Al's oil (Hampton Research) at 20°C, the
crystals were flash-frozen in a nitrogen stream at 100 K.
Preparation of oxy: FdO2 crystals
Crystals of Oxy: Fdrest were soaked in a crystallization
solution containing 20% (v/v) glycerol and 20 mM so-
dium dithionite covered with Al's oil for 20 min at 20°C.
The crystals were then transferred to a crystallization so-
lution containing glycerol without sodium dithionite at
20°C under aerobic condition. Finally, the crystals were
cryo-cooled in liquid nitrogen.
Preparation of oxy: FdCAR-O2 crystals
The crystals of Oxy: Fdred-CAR, which were prepared as
described above, were transferred to a crystallization so-
lution containing 20% (v/v) glycerol, 5% (v/v) dimethyl-
sulfoxide, and 0.25% (w/v) CAR without sodium
dithionite for 10 min at 20°C under aerobic condition.
The crystals were then cryo-cooled in liquid nitrogen.
Measurement of UV-visible absorption spectra of the
rieske cluster
Absorption spectra from the mixed solution of CARDO-
O and CARDO-F, which was used for crystallization
(2 mg/ml in 50 mM Tris–HCl,pH 7.5), were taken at
room temperature as described previously [51]. Absorp-
tion spectra of crystals of Oxy: Fdrest, Oxy: Fdred, and
Oxy: FdO2 were measured with a microspectrophot-
ometer under cryo-stream of nitrogen at 100 K [16,39].
Data collection
The X-ray diffraction data for the three complex crystals
were collected at 100 K on the beamline AR-NW12A at
Photon Factory and BL41XU at SPring-8. All diffraction
data were gathered with a wavelength of 1.0 Å and pro-
cessed with HKL2000 software [52]. The data collection
and processing statistics are given in Table 1.
Molecular replacement, model building, and refinement
The structures of Oxy: Fdrest (2DE5) and Oxy: FdCAR
(2DE7) were used as molecular replacement models for
the program Molrep [53]. Refinement and model build-
ing in the electron density map were carried out with
the Quanta (Accelrys, San Diego, CA, USA) and Xtal-
view [54] programs. Refinement was carried out using
the Refmac5 program in CCP4 [55] and CNS 1.1 [56] by
gradually adding water molecules. The stereochemistry
of the model was analyzed using the Procheck [57],
Whatcheck [58], and RAMPAGE [40] programs. All
descriptions of crystal structures were generated using
PyMOL [59]. Modeling of the exogenous atoms in
oxygen-bound complex structures was carried out
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[13]. In brief, we first refined those crystal structures
without exogenous atoms. The resultant 2Fo-Fc and Fo-
Fc maps showed a large electron density beside the non-
heme iron. One oxygen atom was then modeled in the
electron density. The crystallographic refinement with
one oxygen atom, however, still gave an excess residual
electron density besides the oxygen atom. Therefore, we
placed a dioxygen molecule into the electron density of
the map and refined the structure. The obtained Fo-Fc
map for the structure showed no residual electron dens-
ity around the nonheme iron, but the chemical nature of
these exogenous atoms was unclear. To determine the
type of dioxygen species present in the crystals, we
refined the dioxygen species with an unrestrained O–O
distance. Further assessment for this model was carried
out using a simulated annealing omit map for each lig-
and atom. The omit map for each atom of the diatomic
molecule resulted in a residual electron density at the
position of the omitted atom.
Superimposition of the protein structures
Least-squares comparisons of various complex struc-
tures were carried out using the programs Coot [60] and
PyMOL [59].
Accession numbers
The atomic coordinates and structure factors have been
deposited in the Protein Data Bank, www.pdb.org (PDB
codes 3VMG, 3VMH, and 3VMI for reduced carbazole-
bound complex, oxygen-bound complex, and carbazole-
and oxygen-bound complex, respectively).
Additional file
Additional file 1: Title of data: Figure S1 Illustrations of the active
site in complex structures. Description of data: All panels show the
active site of chain C in complex structures. (A) Binding of CAR at the
active site of Oxy: Fdred-CAR [(3) in Figure 1]. The omitted density map
(Fo-Fc) is shown as a black wire mesh and contoured at 3.5 δ. Only the
nonheme iron (sphere), waters liganded to the iron (small sphere),
iron-coordinated residues (H183, H187, and D333; stick), and CAR (stick)
are shown and colored magenta. (B) Binding of dioxygen to the
nonheme iron in Oxy: FdO2 [(3’) in Figure 1]. Dioxygen molecule is shown
as stick-and-ball and the presentation of other atoms is identical to that
in panel (A), and their color coding is salmon. The black map is an Fo-Fc
omit map (5 δ) of both dioxygen atoms. The green and red maps are
Fo-Fc omit maps (5 δ) for the O1 atom and O2 atom, respectively,
of the dioxygen molecule. (C) Binding of dioxygen molecule at the active
site with the presence of CAR in Oxy: FdCAR-O2 [(4) in Figure 1]. Color
coding is white. The Fo-Fc omit maps (2.5 δ) of CAR, both dioxygen
atoms, the O1 atom, and the O2 atom are colored cyan, black, green,
and red, respectively.
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